Pricing Log in Create free account
Friday 6 November 2026 Export HLN’s income statement to Excel — free account

Haleon PLC Sponsored ADR

HLN Healthcare Drug Manufacturers Specialty & Generic

Haleon PLC Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $14.5 billion, up 1.33% from fiscal 2024.

9.13 0.10 −1.08%
Market cap
$40.2B
P/E
20.5×
Fwd P/E
16.5×
Dividend yield
2.16%
F-score
8/9
Altman Z
3.04
Beneish M
−2.60
Dividend safety
63/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Haleon PLC Sponsored ADR (HLN) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Haleon PLC Sponsored ADR (HLN) trades at a EV/Sales of 2.9×. Over the past ten years it has ranged from 0.0× (March 2024) to 3.5× (June 2025); the current reading is higher than 51% of that period. That is in line with the Drug Manufacturers Specialty & Generic industry median of 2.9× and below the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 3.1× 4.66%
FY2024 3.0× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 0.0× —

Quarterly newest first

Period EV/Sales Change
Sep 2024 3.3× 18.19%
Mar 2024 2.8× —
Sep 2023 0.0× —
Jun 2023 0.0× —
1 more quarters

Against its own ten years

Low 0.0× High 3.5×
Ten-year median 2.9×
Current reading's percentile 51

EV/Sales against peers

Company EV/Sales
VTRS Viatris Inc. compare 2.3×
HLN Haleon PLC Sponsored ADR 2.9×
ELAN Elanco Animal Health Incorporated compare 3.0×
TAK Takeda Pharmaceutical Co. compare 3.1×
TEVA Teva Pharmaceutical Industries Ltd. compare 3.6×
RDY Dr. Reddy's Laboratories Ltd compare 3.6×
NBIX Neurocrine Biosciences, Inc. compare 4.4×
ZTS Zoetis Inc. compare 4.5×
UTHR United Therapeutics Corporation compare 6.6×
Drug Manufacturers Specialty & Generic industry median 2.9×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on HLN